NCT06100731

Brief Summary

Large samples (\~2,000/yr) of adult undergraduate students at a large southern university will be pre-screened via the University of Kentucky SONA System (IRB#43626) to identify and recruit adult female participants who report a history of IPV and probable PTSD to participate in a one-day lab study. After completing an IRB-approved informed consent, participants will complete a brief psychiatric diagnostic interview and a battery of questionnaires. They will then complete three blocks of the Stop Signal Task (SST). Participants will be randomized (double-blind, stratified by PTSD diagnosis and psychotropic medication use) to receive 15-min of active or sham multifocal tDCS targeting the rIFG. tDCS will be delivered offline for 11.5-mins after block 1 of the SST and online for 3.5-mins during block 2 of the SST. Sham stimulation will be identical to active tDCS, but electrical current will only be ramped in/out at the beginning and end of the 15-mins. The third block of the SST will be completed after tDCS. Lastly, participants will complete a pictorial trauma-related symptom provocation task. Participants will be compensated with course credit.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

October 27, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2024

Completed
Last Updated

January 16, 2025

Status Verified

January 1, 2025

Enrollment Period

1.1 years

First QC Date

October 4, 2023

Last Update Submit

January 15, 2025

Conditions

Keywords

noninvasive brain stimulationinhibitory controltranscranial direct current stimulation

Outcome Measures

Primary Outcomes (3)

  • Stop Signal Reaction Time (SSRT)

    SSRT is a measure of inhibitory control that is calculated by subtracting the mean stop signal delay on "stop" trials from the mean response time on "go" trials

    Day 1

  • Skin conductance level (SCL)

    SCL will be measured by collecting electrodermal activity (EDA) on the left hand. Mean SCL during trauma related images will be utilized as a measure of emotional reactivity to trauma-related images.

    Day 1

  • Heart Rate (HR)

    HR will be measured using a photophylesmograph on the left hand. Mean HR during trauma related images will be utilized as a measure of emotional reactivity to trauma-related images.

    Day 1

Study Arms (2)

Active tDCS

ACTIVE COMPARATOR

Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period and a constant current will be delivered for the 15-minutes between ramping

Device: tDCS

Shame tDCS

SHAM COMPARATOR

Current will be ramped in/out for 15 seconds at the beginning and end of a 15-minute period during which no stimulation will be delivered.

Device: tDCS

Interventions

tDCSDEVICE

Subjects will receive 20 minutes of multifocal transcranial direct current stimulation. The anode will be placed over the frontal pole (FC6, 10-10 EEG) and will be surrounded by 5 return electrodes (cathodes). Current will be set at 1.5mA and will be ramped in/ out at the beginning and end of the 15-minutes of stimulation over the course of 15 seconds.

Also known as: Starstim®, transcranial direct current stimulation, transcranial electrical stimulation
Active tDCSShame tDCS

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Ability to provide informed consent
  • Ability and willingness to perform procedures
  • Age 18-55
  • Female sex
  • Meet diagnostic criteria for past-month probable IPV-related PTSD.
  • Medication free or stable (≥4 weeks) medication(s)

You may not qualify if:

  • Unstable medical, psychiatric, or neurological condition that may necessitate urgent treatment
  • Contraindications for tDCS
  • History of psychosis, mania, major neurological disorder, significant head trauma, or epilepsy.
  • Daily use of psychostimulant medication
  • Daily use of medications that significantly lower seizure threshold
  • Current suicidal intent
  • History of seizures
  • Current pregnancy
  • Moderate severity substance-use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40506, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Gopalkumar Rakesh, PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Randomization (stratified by PTSD status and medication use) into active or shame tDCS. Double blind software will be used to ensure that the experimenter and the subject remain blind during task administration.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Subjects will be randomly assigned to receive Active (real) or Sham (placebo) transcranial direct current stimulation.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 4, 2023

First Posted

October 25, 2023

Study Start

October 27, 2023

Primary Completion

December 4, 2024

Study Completion

December 4, 2024

Last Updated

January 16, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Upon data de-identification, data will be available upon request after study publication. Upon request, other supporting documents (e.g., study protocol and analytic code) will also be available

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
May 2025 for 9 years.
Access Criteria
* Must be a doctoral-level researcher. * Must request documents from the PI or Co-I of the study.

Locations